# HYLENEX Recombinant

NDC: 18657-117
Generic name: Hyaluronidase
Labeler / Manufacturer: Antares Pharma, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20051202

FDA application: BLA021859

## Active ingredients

- HYALURONIDASE (HUMAN RECOMBINANT): 150 [USP'U]/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"18657-117"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=18657-117
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3023cc56-ed4b-4e87-b3a1-81b20943f658